Personalized Medicine in Clinical Pharmaceutics
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Clinical Pharmaceutics".
Deadline for manuscript submissions: 20 March 2026 | Viewed by 17
Special Issue Editor
Special Issue Information
Dear Colleagues,
Pharmaceutics is pleased to announce a Special Issue entitled “Personalized Medicine in Clinical Pharmaceutics”. Personalized medicine is revolutionizing healthcare by enabling the tailoring of treatments to individual characteristics, such as health exposure, genetic profiles, disease phenotypes, and lifestyle factors. In clinical pharmaceutics and pharmaceutical care, this approach is driving advancements in drug formulation, delivery systems, and treatment applications to optimize efficacy while minimizing adverse effects. Technologies such as 3D printing, nanotechnology, pharmacogenomics-based drug selection, adaptive drug delivery systems, and AI-based applications are enabling the development of patient-specific dosage forms and individualized treatment regimens.
This Special Issue will focus on cutting-edge research in the design, development, and evaluation of personalized pharmaceutics, including precision formulations, target-specific drug delivery platforms, and real-time monitoring systems for individualized therapy.
We invite researchers, clinicians, and industry professionals to contribute original research and reviews on personalized pharmaceutical science and patient care optimization for improved patient outcomes. We look forward to receiving your contributions.
Prof. Dr. Sandy Jeong Rhie
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- personalized medicine
- precision pharmaceutics
- therapy optimization
- pharmacogenomics
- 3D printing
- nanotechnology
- targeted drug delivery
- individualized therapy
- patient-specific formulations
- adaptive drug delivery
- clinical pharmaceutics
- pharmaceutical care
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
